VECT-HORUS will attend BIO Europe from March 25–26, 2019
If you are interested to meet, please use the B2B Partnering system.
https://ebdgroup.knect365.com/bioeu...
Home > Keywords > Thématique > Agenda
Agenda
Articles
-
Meet Vect-Horus at BIO Spring Vienna
18 January 2019, by Jonathan NOWAK -
11th International Conference on Cerebral Vascular Biology
28 January 2019, by Jonathan NOWAKVECT-HORUS is sponsoring the 11th International Conference on Cerebral Vascular Biology (CVB 2015).
-
Biopharm America 2015
28 January 2019, by Jonathan NOWAKVECT-HORUS will be present at Biopharm America 2015.
-
Vect-Horus confirmed to attend BioPharm America 2017
28 January 2019, by Jonathan NOWAK26-27/09/2017
Boston USA
ebdgroup.knect365.com/biopharm-america/ -
Nanomedicine for treating cancer and brain diseases symposium in MARSEILLE
6 March 2019, by Jonathan NOWAKIn the context of the Euronanomed projects for Action on Nanomedicine under Horizon 2020, a Symposium will be held at the Luminy campus in Marseille on March 8, 2019. Dr. Khrestchatisky will give a talk titled "Molecular vectors for drug delivery into the brain and tumors".
For more information, please visit the symposium website or download the pdf version of the program. -
Vect-Horus will be attending the EANM’19 Congress in Barcelona
3 September 2019, by Elodie DORMESCedric MALICET PhD, Oncology Project Manager and Elodie DORMES, Business Development Manager will attend EANM from 12-16 October, 2019 in Barcelona to discuss Peptide Receptor Radionuclide Therapy strategy and partnered Vect-Horus’ products.
-
8th Edition of BioFIT for the first time in MARSEILLE
4 December 2019, by Elodie DORMESVect-Horus will be present at the BioFIT partnering event on December 10th, 2019 in Marseille.
-
Meet Vect-Horus at BIO Japan
3 September 2019, by Elodie DORMESDr Jamal TEMSAMANI, Drug Development and Corporate Director will attend BIO Japan from October 9–11, 2019
If you are interested to meet, please use the B2B Partnering system. -
CNS Barrier Congress
28 January 2019, by Jonathan NOWAK22-23 March 2017 // Holiday Inn London Kensington Hotel
-
Selected for a 5’ Pitch at the 2nd edition of the TOULOUSE ONCO WEEK
28 January 2019, by Jonathan NOWAKCédric MALICET, PhD Oncology Project Manager, will present VECT-HORUS’ proprietary technology platform, VECTrans®, that facilitates the targeted delivery of imaging or therapeutic agents to tumors using receptor mediated transport.
http://www.toulouse-onco-week.org/index.php?langue=en&onglet=0&acces=&idUser=&emailUser=